Entera Bio ENTX
NASDAQ ENTX
$2.86 -0.03 (-1.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Entera Bio (ENTX) Short-term Investments (2017 - 2021)

Updated

Entera Bio (ENTX) reported Short-term Investments of $863,000 for Q2 2021, up 27.5% from $677,000 a year earlier.

Analysis

Entera Bio (ENTX) Short-term Investments (2017 - 2021) Analysis & Trends

At the end of FY2020, Entera Bio posted Short-term Investments of $261,000, up 50.9% from FY2019.

  • Short-term Investments has a three-year compound annual growth rate of -27.0% (FY2017 to FY2020).
  • By year, Short-term Investments came in at $173,000 in FY2019 (-21.4%), $220,000 in FY2018 (-67.2%) and $671,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Entera Bio 142.45 Mn 111.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 863,000.00
Dec 31, 2020 261,000.00
Jun 30, 2020 677,000.00
Dec 31, 2019 173,000.00
Dec 31, 2018 220,000.00
Dec 31, 2017 671,000.00
API Access

Entera Bio Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=ENTX&period=max&api_key=YOUR_API_KEY